COMMONWEALTH BIOTECHNOLOGIES INC
10QSB/A, EX-27.1, 2000-05-31
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: COMMONWEALTH BIOTECHNOLOGIES INC, 10QSB/A, 2000-05-31
Next: A C MOORE ARTS & CRAFTS INC, S-8, 2000-05-31



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
FOR MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                                    3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                         653,634
<SECURITIES>                                         0
<RECEIVABLES>                                  498,723
<ALLOWANCES>                                         0
<INVENTORY>                                    169,065
<CURRENT-ASSETS>                             1,321,422
<PP&E>                                       8,282,978
<DEPRECIATION>                               1,264,374
<TOTAL-ASSETS>                               9,051,181
<CURRENT-LIABILITIES>                        1,012,047
<BONDS>                                      4,000,000
                                0
                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 9,051,181
<SALES>                                      1,185,881
<TOTAL-REVENUES>                             1,185,881
<CGS>                                                0
<TOTAL-COSTS>                                1,030,796
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              85,331
<INCOME-PRETAX>                                 76,676
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             76,676
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    76,676
<EPS-BASIC>                                       0.05
<EPS-DILUTED>                                     0.04


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission